Showing results (251-260 of 261) with videos related to

Sort By:
Pageof 27
Nature Reviews. Gastroenterology & Hepatology|February 9, 2023
Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevanceDiego F Calvisi, Luke Boulter, Javier Vaquero, et al.
The Lancet. Infectious Diseases|January 12, 2020
Zoonotic spillover infections with Borna disease virus 1 leading to fatal human encephalitis, 1999-2019: an epidemiological investigationHans Helmut Niller, Klemens Angstwurm, Dennis Rubbenstroth, et al.
Lancet (London, England)|July 6, 2024
Assessing the efficacy and tolerability of PET-guided BrECADD versus eBEACOPP in advanced-stage, classical Hodgkin lymphoma (HD21): a randomised, multicentre, parallel, open-label, phase 3 trialPeter Borchmann, Justin Ferdinandus, Gundolf Schneider, et al.
Virchows Archiv : an International Journal of Pathology|April 2, 2022
Organ manifestations of COVID-19: what have we learned so far (not only) from autopsies?Danny Jonigk, Christopher Werlein, Till Acker, et al.
European Urology|January 9, 2021
European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines PanelRichard J Sylvester, Oscar Rodríguez, Virginia Hernández, et al.
Urologic Oncology|November 10, 2019
Papillary urothelial neoplasm of low malignant potential (PUN-LMP): Still a meaningful histo-pathological grade category for Ta, noninvasive bladder tumors in 2019?Anouk E Hentschel, Bas W G van Rhijn, Johannes Bründl, et al.
European Urology Oncology|January 20, 2023
Prognosis of Primary Papillary Ta Grade 3 Bladder Cancer in the Non-muscle-invasive SpectrumIrene J Beijert, Anouk E Hentschel, Johannes Bründl, et al.
European Urology Focus|May 16, 2022
T1G1 Bladder Cancer: Prognosis for this Rare Pathological Diagnosis Within the Non-muscle-invasive Bladder Cancer SpectrumIrene J Beijert, Anouk E Hentschel, Johannes Bründl, et al.
International Urology and Nephrology|November 19, 2023
Second TURB, restaging TURB or repeat TURB in primary T1 non-muscle invasive bladder cancer: impact on prognosis?Irene J Beijert, Anouk E Hentschel, Johannes Bründl, et al.
European Urology Oncology|May 21, 2025
Towards Defining Follow-up Strategies for Patients with Primary Intermediate-risk Non-muscle-invasive Bladder CancerRoberto Contieri, Alberto Martini, Irene J Beijert, et al.
Pageof 27